Mira Pharmaceuticals, Inc.

Mira Pharmaceuticals, Inc. (MIRA) priced its initial public offering on Aug 4, 2023 at $7.00 per share, raising $8.9M, and listed on Nasdaq Capital Market. At the IPO price its market capitalization was about $103.2M. Kingswood was lead-left underwriter. Foley & Lardner advised the company and Lucosky Brookman advised the underwriters.

MIRA Pharmaceuticals, Inc. is an early pre-clinical-stage pharmaceutical company developing MIRA1a, a synthetic THC analog under investigation for adult patients with anxiety and cognitive decline associated with early-stage dementia, who also often have chronic pain.

Status

IPO

Ticker

MIRA

Exchange

Nasdaq Capital Market

Priced

Aug 4, 2023

IPO price

$7.00

Raised

$8.9M

Market cap at IPO price

$103.2M

First filed

Jun 29, 2023

Underwriters

Kingswood

Company counsel

Foley & Lardner

Underwriters' counsel

Lucosky Brookman

Sector

Biotech & pharma

Country / state

FL

Market cap at IPO price = shares outstanding after the offering (all classes, before the over-allotment option) × the IPO price, from the final prospectus.